{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:09:06Z","timestamp":1789996146031,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10096-026-05550-0","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:42:52Z","timestamp":1779849772000},"page":"2763-2775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined therapy with nebulized and intravenous colistin for the treatment of multidrug resistance pneumonia in burn patients: experience from a third referral burn care center in Mexico City"],"prefix":"10.1007","volume":"45","author":[{"given":"Marco Antonio","family":"Delaye-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Paola","family":"Aguilar-Rodea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Francisco","family":"Cardona-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Adriana","family":"Col\u00edn-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Hern\u00e1ndez-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Ch\u00e1vez-Heres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Consuelo","family":"Martinez-Wbaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Artemio","family":"G\u00f3mez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Esa\u00fa","family":"L\u00f3pez-J\u00e1come","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Franco-Cendejas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"5550_CR1","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.3390\/ijms24043749","volume":"24","author":"W \u017bwiere\u0142\u0142o","year":"2023","unstructured":"\u017bwiere\u0142\u0142o W, Piorun K, Sk\u00f3rka-Majewicz M, Maruszewska A, Antoniewski J, Gutowska I, Burns (2023) Classification, Pathophysiology, and Treatment: A Review. Int J Mol Sci 24:3749. https:\/\/doi.org\/10.3390\/ijms24043749","journal-title":"Int J Mol Sci"},{"key":"5550_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.suc.2023.02.005","volume":"103","author":"JL Kiley","year":"2023","unstructured":"Kiley JL, Greenhalgh DG (2023) Infections in Burn Patients. Surg Clin North Am 103:427\u2013437. https:\/\/doi.org\/10.1016\/j.suc.2023.02.005","journal-title":"Surg Clin North Am"},{"key":"5550_CR3","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1093\/cid\/cix682","volume":"65","author":"AM Lachiewicz","year":"2017","unstructured":"Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, Van Duin D (2017) Bacterial Infections After Burn Injuries: Impact of Multidrug Resistance. Clin Infect Dis 65:2130\u20132136. https:\/\/doi.org\/10.1093\/cid\/cix682","journal-title":"Clin Infect Dis"},{"key":"5550_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.burns.2006.02.008","volume":"32","author":"BR Sharma","year":"2006","unstructured":"Sharma BR, Harish D, Singh VP, Bangar S (2006) Septicemia as a cause of death in burns: An autopsy study. Burns 32:545\u2013549. https:\/\/doi.org\/10.1016\/j.burns.2006.02.008","journal-title":"Burns"},{"key":"5550_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.burns.2012.09.017","volume":"39","author":"P Krishnan","year":"2013","unstructured":"Krishnan P, Frew Q, Green A, Martin R, Dziewulski P (2013) Cause of death and correlation with autopsy findings in burns patients. Burns 39:583\u2013588. https:\/\/doi.org\/10.1016\/j.burns.2012.09.017","journal-title":"Burns"},{"key":"5550_CR6","doi-asserted-by":"publisher","unstructured":"Chan C-H, Yang S-F, Yeh H-W, Yeh Y-T, Wang Y-H, Teng Y-H et al Risk of pneumonia in patients with burn injury: a population-based cohort study. Clin Epidemiol 2018;Volume 10:1083\u20131091. https:\/\/doi.org\/10.2147\/CLEP.S172980","DOI":"10.2147\/CLEP.S172980"},{"key":"5550_CR7","first-page":"128","volume":"28","author":"E Liodaki","year":"2015","unstructured":"Liodaki E, Kalousis K, Mauss KL, Kisch T, Mailaender P, Stang F (2015) Epidemiology of pneumonia in a burn care unit: the influence of inhalation trauma on pneumonia and of pneumonia on burn mortality. Ann Burns Fire Disasters 28:128\u2013133","journal-title":"Ann Burns Fire Disasters"},{"key":"5550_CR8","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/jbcr\/irad099","volume":"44","author":"NC Ronkar","year":"2023","unstructured":"Ronkar NC, Galet C, Richey K, Foster K, Wibbenmeyer L (2023) Predictors and Impact of Pneumonia on Adverse Outcomes in Inhalation Injury Patients. J Burn Care Res 44:1289\u20131297. https:\/\/doi.org\/10.1093\/jbcr\/irad099","journal-title":"J Burn Care Res"},{"key":"5550_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/bcpt.13482","volume":"128","author":"K Ram","year":"2021","unstructured":"Ram K, Sheikh S, Bhati RK, Tripathi CD, Suri JC, Meshram GG (2021) Steady-state pharmacokinetic and pharmacodynamic profiling of colistin in critically ill patients with multi-drug-resistant gram-negative bacterial infections, along with differences in clinical, microbiological and safety outcome. Basic Clin Pharmacol Toxicol 128:128\u2013140. https:\/\/doi.org\/10.1111\/bcpt.13482","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"5550_CR10","doi-asserted-by":"publisher","unstructured":"Zhang Y, Wang C, Chen J, Bai C, Sun D, Qiu Y et al (2025) Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study. Front Pharmacol 15. https:\/\/doi.org\/10.3389\/FPHAR.2024.1466888","DOI":"10.3389\/FPHAR.2024.1466888"},{"key":"5550_CR11","doi-asserted-by":"publisher","first-page":"967412","DOI":"10.3389\/fphar.2022.967412","volume":"13","author":"Y-L Xie","year":"2022","unstructured":"Xie Y-L, Jin X, Yan S-S, Wu C-F, Xiang B-X, Wang H et al (2022) Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients. Front Pharmacol 13:967412. https:\/\/doi.org\/10.3389\/fphar.2022.967412","journal-title":"Front Pharmacol"},{"key":"5550_CR12","unstructured":"Ncezid CDC DHQP. Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event 2025:6\u201319"},{"key":"5550_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/PHAR.2209","volume":"39","author":"BT Tsuji","year":"2019","unstructured":"Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL, Forrest A et al (2019) International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America. (ID\u2026 Pharmacotherapy 39:10\u201339. https:\/\/doi.org\/10.1002\/PHAR.2209;WEBSITE:WEBSITE:ACCPJOURNALS;WGROUP:STRING:PUBLICATION","journal-title":"(ID\u2026 Pharmacotherapy"},{"key":"5550_CR14","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/AAC.01733-10;SUBPAGE:STRING:FULL","volume":"55","author":"SM Garonzik","year":"2011","unstructured":"Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J et al (2011) Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 55:3284\u20133294. https:\/\/doi.org\/10.1128\/AAC.01733-10;SUBPAGE:STRING:FULL","journal-title":"Antimicrob Agents Chemother"},{"key":"5550_CR15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/CID\/CIY381","volume":"67","author":"JM Miller","year":"2018","unstructured":"Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH et al (2018) A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 67:e1\u201394. https:\/\/doi.org\/10.1093\/CID\/CIY381","journal-title":"Clin Infect Dis"},{"key":"5550_CR16","doi-asserted-by":"publisher","unstructured":"Wormser GP, Stratton C (2007) Manual of Clinical Microbiology, 9th Edition Edited by Patrick R. Murray, Ellen Jo Baron, James H. Jorgensen, Marie Louise Landry, and Michael A. Pfaller Washington, DC: ASM Press, 2488 pp., illustrated. $209.95 (hardcover). Clinical Infectious Diseases 2008;46:153\u2013153. https:\/\/doi.org\/10.1086\/524076","DOI":"10.1086\/524076"},{"key":"5550_CR17","doi-asserted-by":"crossref","unstructured":"Respiratory Tract Cultures. Clinical Microbiology Procedures Handbook, John Wiley & Sons, Ltd (2016) p. 3.11.1.1\u20133.11.9.4","DOI":"10.1128\/9781555818814.ch3.11.1"},{"key":"5550_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0025-6196(25)09678-8","volume":"50","author":"PR Murray","year":"1975","unstructured":"Murray PR, Washington JA (1975) Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 50:339\u2013344","journal-title":"Mayo Clin Proc"},{"key":"5550_CR19","unstructured":"EM100 Connect - CLSI M100 ED36:2026 (2026) n.d. https:\/\/em100.edaptivedocs.net\/GetDoc.aspx?doc=CLSI%20M100%20ED36:2026&scope=user"},{"key":"5550_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"5550_CR21","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/molecules25061340","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Jubeh B, Karaman R (2020) Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules 25:1340. https:\/\/doi.org\/10.3390\/molecules25061340","journal-title":"Molecules"},{"key":"5550_CR22","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE et al (2024) Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404:1199\u20131226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1","journal-title":"Lancet"},{"key":"5550_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jbcr\/irae075","volume":"45","author":"R Elsheikh","year":"2024","unstructured":"Elsheikh R, Makram AM, Multidrug-Resistant, Organisms (2024) The Silent Plight of Burn Patients. J Burn Care Res 45:877\u2013886. https:\/\/doi.org\/10.1093\/jbcr\/irae075","journal-title":"J Burn Care Res"},{"key":"5550_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/jbcr\/irz177","volume":"41","author":"LE L\u00f3pez-J\u00e1come","year":"2020","unstructured":"L\u00f3pez-J\u00e1come LE, Ch\u00e1vez-Heres T, Becerra-Lobato N, Garc\u00eda-Hern\u00e1ndez M, de L, Vanegas-Rodr\u00edguez ES, Colin-Castro CA et al (2020) Microbiology and Infection Profile of Electric Burned Patients in a Referral Burn Hospital in Mexico City. J Burn Care Res 41:390\u2013397. https:\/\/doi.org\/10.1093\/jbcr\/irz177","journal-title":"J Burn Care Res"},{"key":"5550_CR25","doi-asserted-by":"publisher","unstructured":"Fuentes-Gonz\u00e1lez MF, Fern\u00e1ndez-Rodr\u00edguez D, Col\u00edn-Castro CA, Hern\u00e1ndez-Dur\u00e1n M, L\u00f3pez-J\u00e1come LE, Franco-Cendejas R (2024) Gram-Negative Bacilli Blood Stream Infection in Patients with Severe Burns: Microbiological and Clinical Evidence from a 9-Year Cohort. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/IJMS251910458","DOI":"10.3390\/IJMS251910458"},{"key":"5550_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00134-010-1879-4","volume":"36","author":"Q Lu","year":"2010","unstructured":"Lu Q, Girardi C, Zhang M, Bouhemad B, Louchahi K, Petitjean O et al (2010) Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med 36:1147\u20131155. https:\/\/doi.org\/10.1007\/s00134-010-1879-4","journal-title":"Intensive Care Med"},{"key":"5550_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13613-016-0140-x","volume":"6","author":"M Bassetti","year":"2016","unstructured":"Bassetti M, Luyt C-E, Nicolau DP, Pugin J (2016) Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient. Ann Intensive Care 6:35. https:\/\/doi.org\/10.1186\/s13613-016-0140-x","journal-title":"Ann Intensive Care"},{"key":"5550_CR28","doi-asserted-by":"publisher","unstructured":"Abdellatif S, Trifi A, Daly F, Mahjoub K, Nasri R, Ben Lakhal S Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial. Ann Intensive Care 2016;6. https:\/\/doi.org\/10.1186\/S13613-016-0127-7","DOI":"10.1186\/S13613-016-0127-7"},{"key":"5550_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmi.2017.04.011","volume":"23","author":"J Rello","year":"2017","unstructured":"Rello J, Sol\u00e9-Lleonart C, Rouby JJ, Chastre J, Blot S, Poulakou G et al (2017) Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect 23:629\u2013639. https:\/\/doi.org\/10.1016\/j.cmi.2017.04.011","journal-title":"Clin Microbiol Infect"},{"key":"5550_CR30","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.4187\/RESPCARE.04519","volume":"61","author":"C Sol\u00e9-Lleonart","year":"2016","unstructured":"Sol\u00e9-Lleonart C, Rouby JJ, Chastre J, Poulakou G, Palmer LB, Blot S et al (2016) Intratracheal administration of antimicrobial agents in mechanically ventilated adults: An international survey on delivery practices and safety. Respir Care 61:1008\u20131014. https:\/\/doi.org\/10.4187\/RESPCARE.04519","journal-title":"Respir Care"},{"key":"5550_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cmi.2015.12.016","volume":"22","author":"C Sol\u00e9-Lleonart","year":"2016","unstructured":"Sol\u00e9-Lleonart C, Roberts JA, Chastre J, Poulakou G, Palmer LB, Blot S et al (2016) Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines. Clin Microbiol Infect 22:359\u2013364. https:\/\/doi.org\/10.1016\/j.cmi.2015.12.016","journal-title":"Clin Microbiol Infect"},{"key":"5550_CR32","first-page":"135","volume":"25","author":"AD Rogers","year":"2012","unstructured":"Rogers AD, Argent AC, Rode H (2012) Review article: ventilator-associated pneumonia in major burns. Ann Burns Fire Disasters 25:135\u2013139","journal-title":"Ann Burns Fire Disasters"},{"key":"5550_CR33","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1089\/MDR.2019.0354","volume":"26","author":"E Garza-Gonz\u00e1lez","year":"2020","unstructured":"Garza-Gonz\u00e1lez E, Franco-Cendejas R, Morf\u00edn-Otero R, Echaniz-Aviles G, Rojas-Larios F, Bocanegra-Ibarias P et al (2020) The Evolution of Antimicrobial Resistance in Mexico During the Last Decade: Results from the INVIFAR Group. Microb Drug Resist 26:1372\u20131382. https:\/\/doi.org\/10.1089\/MDR.2019.0354","journal-title":"Microb Drug Resist"},{"key":"5550_CR34","doi-asserted-by":"publisher","unstructured":"Rojas-Larios F, Mart\u00ednez-Guerra BA, L\u00f3pez-J\u00e1come LE, Bolado-Mart\u00ednez E, V\u00e1zquez-Larios Mdel, del R, Vel\u00e1zquez-Acosta M C, Active Surveillance of Antimicrobial Resistance and Carbapenemase-Encoding Genes According to Sites of Care and Age Groups in Mexico: Results from the INVIFAR Network. Pathogens 2023;12. https:\/\/doi.org\/10.3390\/PATHOGENS12091144","DOI":"10.3390\/PATHOGENS12091144"},{"key":"5550_CR35","unstructured":"American Burn Association (2016) NATIONAL BURN REPOSITORY REPORT OF DATA FROM 2006\u20132015. Chicago"},{"key":"5550_CR36","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1378\/chest.13-1018","volume":"144","author":"M Tumbarello","year":"2013","unstructured":"Tumbarello M, De Pascale G, Trecarichi EM, De Martino S, Bello G, Maviglia R et al (2013) Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria. Chest 144:1768\u20131775. https:\/\/doi.org\/10.1378\/chest.13-1018","journal-title":"Chest"},{"key":"5550_CR37","doi-asserted-by":"publisher","unstructured":"Arrayasillapatorn N, Promsen P, Kritmetapak K, Anunnatsiri S, Chotmongkol W, Anutrakulchai S Colistin-Induced Acute Kidney Injury and the Effect on Survival in Patients with Multidrug-Resistant Gram-Negative Infections: Significance of Drug Doses Adjusted to Ideal Body Weight. Int J Nephrol 2021;2021. https:\/\/doi.org\/10.1155\/2021\/7795096","DOI":"10.1155\/2021\/7795096"},{"key":"5550_CR38","doi-asserted-by":"publisher","unstructured":"Katip W, Rayanakorn A, Sornsuvit C, Wientong P, Oberdorfer P, Taruangsri P et al (2024) High-Loading-Dose Colistin with Nebulized Administration for Carbapenem-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients: A Retrospective Cohort Study. Antibiotics 2024, Vol 13, Page 287. ;13:287. https:\/\/doi.org\/10.3390\/ANTIBIOTICS13030287","DOI":"10.3390\/ANTIBIOTICS13030287"},{"key":"5550_CR39","doi-asserted-by":"publisher","first-page":"e49314","DOI":"10.7759\/cureus.49314","volume":"15","author":"L Maan","year":"2025","unstructured":"Maan L, Anand N, Yadav G, Mishra M, Gupta MK (2025) The Efficacy and Safety of Intravenous Colistin Plus Aerosolized Colistin Versus Intravenous Colistin Alone in Critically Ill Trauma Patients With Multi-Drug Resistant Gram-Negative Bacilli Infection. Cureus 15:e49314. https:\/\/doi.org\/10.7759\/cureus.49314","journal-title":"Cureus"},{"key":"5550_CR40","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.cmi.2021.01.020","volume":"27","author":"JY Feng","year":"2021","unstructured":"Feng JY, Peng CK, Sheu CC, Lin YC, Chan MC, Wang SH et al (2021) Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study. Clin Microbiol Infect 27:1465\u20131473. https:\/\/doi.org\/10.1016\/j.cmi.2021.01.020","journal-title":"Clin Microbiol Infect"},{"key":"5550_CR41","first-page":"3","volume":"36","author":"A Wardhana","year":"2023","unstructured":"Wardhana A, Wibowo J (2023) Predicting Mortality in Burn Patients: Literature Review of Risk Factors for Burn Mortality and Application in Scoring Systems. Ann Burns Fire Disasters 36:3\u201310","journal-title":"Ann Burns Fire Disasters"},{"key":"5550_CR42","doi-asserted-by":"publisher","unstructured":"Seghezzi S, Pasquale M, Di, Aliberti S, Marullo G, Monzani V, Brambilla AM et al Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? Eur Respir J 2014;38. https:\/\/doi.org\/10.1183\/13993003\/erj.38.Suppl_55.p2566","DOI":"10.1183\/13993003\/erj.38.Suppl_55.p2566"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05550-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05550-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05550-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:34:21Z","timestamp":1789994061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05550-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5550"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05550-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the Instituto Nacional de Rehabilitaci\u00f3n Luis Guillermo Ibarra Ibarra (16\/23) and is in line with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the study and the mandatory surveillance reporting for HAP and VAP, informed consent was waived.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}